Abstract
Fluorescent coupling of bovine serum albumin (BSA) and extracellular antigen of melanoma (ECA) using modified carbodiimide method was evaluated enabling BSA to serve as model protein to evaluate the release profiles of different microsphere formulations and uptake in B16 melanoma cells. Properties of the fluorescent labeled BSA (FBSA) including stability, transition temperature and fluorescent intensity were evaluated. It was found that FBSA produced using this method showed comparable transition temperature and fluorescent intensity compared to the commercially available FITC-labeled BSA and demonstrated stability of the fluorescent-protein linkage after overnight treatment with both trypsin and human plasma using fluorescent microscope. This study showed that the modified carbodiimide labeling method can serve as an alternative method for fluorescent labeling of target protein at reasonable cost particularly when sufficient amount of target protein is required for microsphere formulation screening.
Keywords: Carbodiimide, covalent coupling, fluorescent, bovine serum albumin, cross-linking, microspheres, phagocytosis, B16 melanoma
Current Drug Delivery
Title: Labeling of Fluorescent Probes to Albumin Microspheres and B16 Melanoma Extra-Cellular Antigen
Volume: 7 Issue: 3
Author(s): Yin Hwa Lai and Martin J. D'Souza
Affiliation:
Keywords: Carbodiimide, covalent coupling, fluorescent, bovine serum albumin, cross-linking, microspheres, phagocytosis, B16 melanoma
Abstract: Fluorescent coupling of bovine serum albumin (BSA) and extracellular antigen of melanoma (ECA) using modified carbodiimide method was evaluated enabling BSA to serve as model protein to evaluate the release profiles of different microsphere formulations and uptake in B16 melanoma cells. Properties of the fluorescent labeled BSA (FBSA) including stability, transition temperature and fluorescent intensity were evaluated. It was found that FBSA produced using this method showed comparable transition temperature and fluorescent intensity compared to the commercially available FITC-labeled BSA and demonstrated stability of the fluorescent-protein linkage after overnight treatment with both trypsin and human plasma using fluorescent microscope. This study showed that the modified carbodiimide labeling method can serve as an alternative method for fluorescent labeling of target protein at reasonable cost particularly when sufficient amount of target protein is required for microsphere formulation screening.
Export Options
About this article
Cite this article as:
Hwa Lai Yin and J. D'Souza Martin, Labeling of Fluorescent Probes to Albumin Microspheres and B16 Melanoma Extra-Cellular Antigen, Current Drug Delivery 2010; 7 (3) . https://dx.doi.org/10.2174/156720110791560982
DOI https://dx.doi.org/10.2174/156720110791560982 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alpha9Alpha10 Nicotinic Acetylcholine Receptors as Target for the Treatment of Chronic Pain
Current Pharmaceutical Design Development and Application of Fourier-Transform Infrared Chemical Imaging of Tumour in Human Tissue
Current Medicinal Chemistry Immunobiologic Agents in Dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules
Current Pharmaceutical Design Brain Tumor Segmentation of T1w MRI Images Based on Clustering Using Dimensionality Reduction Random Projection Technique
Current Medical Imaging Methods of Preparation of Multifunctional Microbubbles and their In Vitro / In Vivo Assessment of Stability, Functional and Structural Properties
Current Pharmaceutical Design Spermine Metabolism and Anticancer Therapy
Current Cancer Drug Targets Pomegranate Extracts and Cancer Prevention: Molecular and Cellular Activities
Anti-Cancer Agents in Medicinal Chemistry Targeting PDK1 in Cancer
Current Medicinal Chemistry Viral and Non-Viral Methods to Genetically Modify Dendritic Cells
Current Gene Therapy Inhibition of Anti-Apoptotic Bcl-2 Family Proteins by Natural Polyphenols New Avenues for Cancer Chemoprevention and Chemotherapy
Current Pharmaceutical Design A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
Current Drug Metabolism CARD Proteins as Therapeutic Targets in Cancer
Current Drug Targets Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-Methoxyestradiol
Current Pharmaceutical Design Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters
Recent Patents on Nanotechnology Surgical Strategies for Fertility Preservation in Women with Cancer
Current Women`s Health Reviews Electrotransfer into Skeletal Muscle for Protein Expression
Current Gene Therapy Pitfalls and Solutions for the Validation of Novel Drugs in Animal Models of Disease
Current Immunology Reviews (Discontinued) Alkaptonuria, Ochronosis and Ochronotic Arthropathy in Mainland France and the Reunion Island. A Report of Clinical and Molecular Findings in 29 Patients
Current Rheumatology Reviews Glioma Targeting and Anti-glioma Effect of Interleukin 13 Peptide and RGD Peptide Dual Functionalized Nanoparticles
Current Pharmaceutical Biotechnology